Borhani stressed that the statistics show an unmet need for developing novel therapeutic strategies to increase durable responses and improve clinical outcomes. Thankfully, she said these new strategies are now emerging.
"In recent years, two new cancer treatment approaches, namely, immunotherapy and targeted therapy, have shown promising results in the laboratory and in clinical trials," Borhani said.
Ruchi Garg, M.D., national program director of Gynecologic Oncology at Cancer Treatment Centers of America, stated that "up until recently, we didn't have any spectacular treatment options for these patients."
She advised that the mainstay of treatment has been chemotherapy and radiation therapy only without much survival advantage in advanced or recurrent disease.
"Now it is such an exciting time with the introduction of immunotherapy, targeted therapies and hopefully soon—therapeutic vaccines," Garg said. "Lots is happening in the world of cervical cancer, which is having an impact on quality of life and survival rates."